BPG is committed to discovery and dissemination of knowledge
Featured Articles
10/31/2024 8:36:36 AM | Browse: 148 | Download: 464
 |
Received |
|
2024-09-02 12:20 |
|
Peer-Review Started |
|
2024-09-02 12:20 |
|
First Decision by Editorial Office Director |
|
2024-09-17 05:58 |
|
Return for Revision |
|
2024-09-17 05:58 |
|
Revised |
|
2024-09-26 17:43 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-10-18 01:32 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-10-20 10:22 |
|
Articles in Press |
|
2024-10-20 10:22 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-10-28 06:00 |
|
Publish the Manuscript Online |
|
2024-10-31 08:01 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Letter to the Editor |
| Article Title |
SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Panayotis K Vlachakis, Panagiotis Theofilis and Dimitris Tousoulis |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dimitris Tousoulis, PhD, Professor, Department of 1st Cardiology, Athens Medical School, National and Kapodistrian University of Athens, Mantouvalou 3, Athens 11527, Greece. drtousoulis@hotmail.com |
| Key Words |
Sodium-dependent glucose transporter 2 inhibitor; Diabetes mellitus; Heart failure; Pathophysiology; Inflammation; Oxidative stress |
| Core Tip |
Sodium-dependent glucose transporter 2 inhibitors show promise in improving cardiac function and reducing cardiovascular risks in patients with type 2 diabetes mellitus and asymptomatic heart failure (HF). Early intervention with these drugs could be key in preventing the progression of diabetic cardiomyopathy, making them an important consideration in managing high-risk diabetic patients before symptoms of HF emerge. |
| Publish Date |
2024-10-31 08:01 |
| Citation |
Vlachakis PK, Theofilis P, Tousoulis D. SGLT2 inhibitors in the prevention of diabetic cardiomyopathy: Targeting the silent threat. World J Cardiol 2024; 16(11): 669-672 |
| URL |
https://www.wjgnet.com/1949-8462/full/v16/i11/669.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v16.i11.669 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
